DE60016038T2 - Neue verwendung von levosimendan - Google Patents

Neue verwendung von levosimendan Download PDF

Info

Publication number
DE60016038T2
DE60016038T2 DE60016038T DE60016038T DE60016038T2 DE 60016038 T2 DE60016038 T2 DE 60016038T2 DE 60016038 T DE60016038 T DE 60016038T DE 60016038 T DE60016038 T DE 60016038T DE 60016038 T2 DE60016038 T2 DE 60016038T2
Authority
DE
Germany
Prior art keywords
levosimendan
treatment
patient
sinus
node
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60016038T
Other languages
German (de)
English (en)
Other versions
DE60016038D1 (de
Inventor
Lasse Lehtonen
Mikhail Ruda
Jeffrey Hosenpud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Oyj filed Critical Orion Oyj
Application granted granted Critical
Publication of DE60016038D1 publication Critical patent/DE60016038D1/de
Publication of DE60016038T2 publication Critical patent/DE60016038T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE60016038T 1999-10-22 2000-10-20 Neue verwendung von levosimendan Expired - Lifetime DE60016038T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI992298 1999-10-22
FI992298 1999-10-22
PCT/FI2000/000915 WO2001028560A1 (en) 1999-10-22 2000-10-20 A new use of levosimendan

Publications (2)

Publication Number Publication Date
DE60016038D1 DE60016038D1 (de) 2004-12-23
DE60016038T2 true DE60016038T2 (de) 2005-12-22

Family

ID=8555494

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60016038T Expired - Lifetime DE60016038T2 (de) 1999-10-22 2000-10-20 Neue verwendung von levosimendan

Country Status (9)

Country Link
US (1) US6911209B1 (enExample)
EP (1) EP1248620B1 (enExample)
JP (1) JP2003512328A (enExample)
AT (1) ATE282414T1 (enExample)
AU (1) AU7928700A (enExample)
CA (1) CA2387920C (enExample)
DE (1) DE60016038T2 (enExample)
ES (1) ES2231277T3 (enExample)
WO (1) WO2001028560A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132275B2 (en) 2010-11-18 2015-09-15 Cardiac Pacemakers, Inc. Automatic determination of chronotropic incompetence using atrial pacing at rest
US11969424B2 (en) 2019-12-16 2024-04-30 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8722776D0 (en) * 1987-09-28 1987-11-04 Smith Kline French Lab Chemical compounds
GB2251615B (en) 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5969017A (en) 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia

Also Published As

Publication number Publication date
CA2387920A1 (en) 2001-04-26
JP2003512328A (ja) 2003-04-02
WO2001028560A1 (en) 2001-04-26
US6911209B1 (en) 2005-06-28
AU7928700A (en) 2001-04-30
ES2231277T3 (es) 2005-05-16
CA2387920C (en) 2008-08-26
EP1248620B1 (en) 2004-11-17
DE60016038D1 (de) 2004-12-23
EP1248620A1 (en) 2002-10-16
ATE282414T1 (de) 2004-12-15

Similar Documents

Publication Publication Date Title
DE69930243T2 (de) Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazu
DE69535234T2 (de) Mittel zur behandlung der allergischen rhinitis und anderer erkrankungen enthaltend descarboethoxyloratadin
DE3390116C2 (de) Verbesserte, Koffein enthaltende, analgetische und antiinflammatorische Mittel
DE3390114T1 (de) Verbesserte analgetische und antiinflammatorische, Ibuprofen enthaltende Zubereitungen und Verfahren zu ihrer Herstellung
DE2823174A1 (de) Arzneimittel fuer die prophylaktische behandlung postoperativer tiefer venenthrombose
EP1635838A2 (de) Prophylaxe und/oder therapie bei der portalen hypertonie
Waagstein et al. Clinical results with prenalterol in patients with heart failure
DE60204694T2 (de) Kombinationstherapie zur behandlung von herzinsuffizienz
DE69131398T2 (de) Verwendung von 5-ht4 rezeptorantagonisten zur behandlung von vorhof-fibrillation und zur vorbeugung von schlaganfall
DE60301862T2 (de) Kombinationsbehandlung bei akutem myokardinfarkt
DE60016038T2 (de) Neue verwendung von levosimendan
DE69903546T2 (de) Levosimendan für die behandlung von pulmonaler hypertonie
DE69919789T2 (de) Loratadin zur Verwendung als Antiarrhythmikum
DE69625210T2 (de) Nicorandil gegen angstneurosen
DE69331008T2 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
JPH01186883A (ja) 抗アテローム性動脈硬化症剤としてのｄｌ‐５‐〔（２ベンジル‐３，４‐ジヒドロ‐２Ｈ‐ベンゾピラン‐６‐イル）メチル〕チアゾリジン‐２，４‐ジオン
Rothbart et al. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia
DE602004005000T2 (de) Methode zur behandlung von niereninsuffizienz
DE60004996T2 (de) Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen
DE2131679A1 (de) 3,4,5-Trimethoxybenzamidocarbonsaeure und ihre Salze sowie Arzneipraeparate
DE60319399T2 (de) Pharmazeutische kombination von tenatoprazole und einem histamin-h2-rezeptor antagonisten
EP0219728B1 (de) Kombinationspräparat
DE3339052A1 (de) Pharmazeutisches praeparat zur verbesserung der biochemischen und verhaltens-parameter bei senilitaet
DE60217336T2 (de) Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens
DE3047811A1 (de) "pharmazeutische verwendung von caroverin und/oder caroverinsalzen sowie caroverinsalze mit xanthinderivat-saeureresten und nicotinsaeurerest

Legal Events

Date Code Title Description
8364 No opposition during term of opposition